SOCS3 Gene: Suppressor of Cytokine Signaling 3

A key negative regulator of JAK/STAT signaling with implications in inflammation, cancer, and metabolic disorders.

Gene Information Card

Symbol SOCS3
Full Name Suppressor of cytokine signaling 3
Gene Type Protein coding
Chromosomal Location 17q25.3
NCBI Gene ID 9021 ncbi.nlm.nih.gov/gene/9021
Ensembl ID ENSG00000184557
UniProt ID O14543
OMIM ID 604176
HGNC ID 19391
Aliases CIS3, SSI-3, ATOD4

Description

The SOCS3 gene encodes suppressor of cytokine signaling 3, a member of the suppressor of cytokine signaling (SOCS) family. SOCS3 is a key negative regulator of cytokine signaling, particularly the JAK/STAT pathway. It inhibits signal transduction by binding to JAK kinases and cytokine receptors, thereby modulating immune responses, inflammation, and cell growth. SOCS3 expression is induced by various cytokines and growth factors, forming a negative feedback loop. Dysregulation of SOCS3 is implicated in inflammatory diseases, autoimmune disorders, and several cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Rheumatoid Arthritis Reduced SOCS3 expression leads to enhanced JAK/STAT signaling and increased inflammatory cytokine production. PMID: 21750548
Inflammatory Bowel Disease SOCS3 deficiency in intestinal epithelial cells promotes inflammation and colitis-associated tumorigenesis. PMID: 24503132
Hepatocellular Carcinoma Hypermethylation of SOCS3 promoter leads to silencing, resulting in constitutive JAK/STAT activation and tumor progression. PMID: 12835555
Type 2 Diabetes SOCS3 impairs insulin signaling by promoting ubiquitin-mediated degradation of IRS-1 and IRS-2. PMID: 15124017
Asthma SOCS3 overexpression in airway epithelium suppresses Th2 responses, while deficiency exacerbates allergic inflammation. PMID: 20037587

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Bone Marrow 8.3 Low
Spleen 7.9 Low
Lung 6.4 Low
Adipose Tissue 5.2 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 Cervical carcinoma; moderate expression
HepG2 12.8 Hepatocellular carcinoma; moderate expression
A549 9.5 Lung carcinoma; low expression
MCF7 7.3 Breast carcinoma; low expression
K562 5.1 Chronic myelogenous leukemia; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.136C>T (p.Arg46Trp) Missense Rare (<0.01%) Impairs SOCS3 function, leading to enhanced JAK/STAT signaling
c.313G>A (p.Val105Met) Missense Rare (<0.01%) Alters protein stability and reduces inhibitory activity
c.452_453del (p.Leu151fs) Frameshift Not reported Loss of function; truncated protein
Promoter hypermethylation Epigenetic Common in cancers Silences SOCS3 expression, leading to constitutive STAT activation
Mutation functional classification

Loss of Function (LOF)

Mutations that reduce or abolish SOCS3's ability to inhibit JAK/STAT signaling, leading to hyperactivation of cytokine pathways.

Gain of Function (GOF)

Rare; not well documented. Overexpression of SOCS3 can suppress anti-tumor immunity.

Dominant Negative (DN)

Some missense mutations may interfere with wild-type SOCS3 function, but evidence is limited.

Pathways

• JAK/STAT signaling pathway
• Cytokine-cytokine receptor interaction
• IL-6 signaling pathway
• Growth hormone signaling
• Leptin signaling pathway

Protein Summary

SOCS3 is a 225-amino acid protein containing a central SH2 domain and a C-terminal SOCS box. It binds to JAK kinases and cytokine receptors, inhibiting their activity and promoting proteasomal degradation. SOCS3 is induced by cytokines such as IL-6, IL-10, and IFN-γ, forming a negative feedback loop. It plays a critical role in regulating immune responses, hematopoiesis, and metabolism. Aberrant SOCS3 expression or function is linked to inflammatory diseases, metabolic disorders, and cancer.

Related Products

Product name Cat.No. Species Gene ID
SOCS3 Knockout BEAS-2B Cell Line EDJ-KZ487 Human 9021 Details Get a Quote
SOCS3 Knockout HeLa Cell Line EDJ-KQ18871 Human 9021 Details Get a Quote
SOCS3 Knockout HCT 116 Cell Line EDJ-KQ18870 Human 9021 Details Get a Quote
SOCS3 Knockout A-549 Cell Line EDJ-KQ18869 Human 9021 Details Get a Quote
SOCS3 Knockout HEK293 Cell Line EDJ-KQ527 Human 9021 Details Get a Quote

Research Areas

Cellular Metabolism and Metabolic Reprogramming: A Complete Map from Pathways to Validated Cell Models

Glucose Metabolism and Energy Homeostasis: Flux Control from Glycolysis to OXPHOS

Validating the Glycolysis-OXPHOS Switch by Gene Knockout

Functional Validation of Glycolytic Enzymes (HK2 / PKM2 / LDHA)

TCA Cycle and Mitochondrial Respiration Readouts

Pentose Phosphate Pathway and NADPH Homeostasis

Regulation of Gluconeogenesis and Glycogen Metabolism

Lactate Metabolism and MCT Transporters

Setting Up the Seahorse Glycolysis Stress Test

Troubleshooting Unstable ECAR/OCR Baselines

2-DG Concentration and Duration for Glycolysis Inhibition

Choosing a Lactate Assay

Why Glycolysis Persists After HK2 Knockout

Measuring Glucose Uptake with 2-NBDG

Glycogen Content Assays

How to Measure Pentose Phosphate Pathway Flux

Lipid Metabolism and Lipotoxicity: From Fatty Acid Oxidation to Lipid Droplet Homeostasis

Fatty Acid Oxidation (CPT1A/ACADM) and Lipotoxicity Validation

De Novo Lipogenesis (ACC/FASN/SCD1): Regulation and Validation

Cholesterol Metabolism and the SREBP/SCAP Pathway

Sphingolipid and Ceramide Metabolism

Lipid Droplet Biology and Perilipins

Phospholipid Metabolism and Membrane Homeostasis

BODIPY vs Oil Red O for Lipid Droplets

Palmitate-Induced Lipotoxicity: Concentration and BSA Conjugation

Using Etomoxir to Inhibit Fatty Acid Oxidation

Triglyceride Quantification Assays

Reading the Phenotype After SCD1 Knockout

Ceramide Detection Methods

Lipid Droplet Isolation and Proteomics

Designing a Cholesterol Efflux Assay

Amino Acid and One-Carbon Metabolism: Nitrogen Balance, Glutaminolysis and Methyl Donors

Glutaminolysis (GLS) and Metabolic Dependency

Serine-Glycine Metabolism and One-Carbon Units

Methionine Cycle and the SAM/SAH Ratio

Nucleotide Metabolism and Antimetabolites

Urea Cycle and Nitrogen Metabolism

Branched-Chain Amino Acid Catabolism

Using CB-839 to Inhibit GLS

Preparing Serine-Free Medium

Measuring the SAM/SAH Ratio

LC-MS Profiling of Nucleotide Pools

Urea Quantification Assays

BCAA Detection and Analysis

Setting Glutamine Concentration in Culture

Designing One-Carbon Flux Tracing

Mitochondrial Metabolism and Reprogramming: OXPHOS, Metabolite Signaling and Cancer

Validating the Warburg Effect and Glycolytic Phenotype

Respiratory Chain Complexes and OXPHOS-Deficient Models

Oncometabolites (Succinate/Fumarate/2-HG) and Epigenetic Crosstalk

Mitochondrial Dynamics and Metabolic Adaptation

Hypoxic Metabolism and HIF Reprogramming

Metabolic Flux and Stable Isotope Tracing

Using Rotenone and Antimycin A

Detecting 2-Hydroxyglutarate

Seahorse Mito Stress Test Parameters

Analyzing 13C Tracing Data

Membrane Potential and OXPHOS Readouts

Building an OXPHOS-Deficient Cell Line

Setting Hypoxic Culture Conditions

Building a Succinate Accumulation Model

Metabolism and Disease: From Obesity and Diabetes to Cancer and Immunometabolism

Insulin Resistance and Glucolipid Metabolic Models

NAFLD/MASH Cell Models and Lipotoxicity

Tumor Metabolic Dependency and Target Validation

Immunometabolism and T Cell Metabolism

Metabolic Syndrome and Adipocyte Models

Synthetic Lethality of Metabolic Enzymes

How to Induce Insulin Resistance In Vitro

Building a Hepatocyte Lipid Droplet Model

Running Seahorse Assays on T Cells

Adipocyte Differentiation Protocol

Designing a Synthetic Lethality Screen

Measuring Metabolism in Tumor Spheroids

High-Glucose High-Fat Culture Conditions

Choosing a Metabolic Disease Model

Custom Metabolic Reporter Cell Lines

Custom Knockout Cell Lines for Metabolic Pathways

Metabolic Phenotyping and Seahorse Analysis Service

Stable Isotope Tracing and Metabolomics Capabilities

Metabolic Model Service Provider Comparison

Single-Cell Metabolomics: A Detection Field Waiting for a Measurement Standard

Spatial Metabolomics: The Location Is the Measurement, and the Preparation Moves It

AI Metabolic Network Modeling: The Bottleneck Is the Constraint Set, Not the Architecture

Metabolite-Epigenetics Crosstalk: From Substrate to Signal, Without the Causal Standard

Metabolism in Organoids and 3D Culture: The Gradient Is the Finding, and It Is Usually Unreported

Contact Us
*
*
*
How did you hear about us: